Table 3

Characteristics for patients receiving a digital rectal examination, stratified by quality metric timing

Patient characteristics≤6 months before Tx
n=3742
6+ months before Tx
n=1479
P value
Age at diagnosis (years), Embedded ImageEmbedded Image65.81±8.8367.54±9.41
Insurance payor type, n (%)
 Private1219 (77.3)357 (22.7)<0.001
 Medicare/Medical2269 (69.5)995 (30.5)
Ethnicity, n (%)
 Non-Hispanic3431 (71.7)1353 (28.3)0.767
 Hispanic281 (72.4)107 (27.6)
Race, n (%)
 Asian423 (73.7)151 (26.3)0.523
 White2809 (71.4)1124 (28.6)
 Other*222 (72.1)86 (27.9)
First line of treatment, n (%)
 Active surveillance248 (44.8)306 (55.2)<0.001
 Chemotherapy137 (64.9)74 (35.1)
 Hormone therapy768 (62.8)455 (37.2)
 Radiation therapy612 (73.6)220 (26.4)
 Surgery1977 (82.3)424 (17.7)
Stage, n (%)
 1332 (62.5)199 (37.5)<0.001
 22102 (74.5)720 (25.5)
 3607 (84.7)110 (15.3)
 4286 (67.6)137 (32.4)
  • Tx, treatment.